Inturai Ventures Corp. said on August 4, 2026 that it is raising up to $1,275,000 through a non-brokered private placement of as many as 8,500,000 units priced at $0.15 each. "Non-brokered" means the company is selling the securities itself rather than through an investment dealer, so no underwriting commission is paid on the base offering.
Each unit consists of one common share and one full share purchase warrant. The warrant allows the holder to buy an additional share at $0.25 for 24 months after closing. Full warrant coverage of this kind means the offering could eventually produce up to 17 million new shares — 8.5 million on closing and another 8.5 million if every warrant is exercised. The company did not disclose its current share count, its cash position or its rate of spending, so the dilution cannot be measured against the existing capital structure from the release alone.
The warrants carry an acceleration clause. If the shares close at $0.35 or above on the Canadian Securities Exchange, or another market where they trade, for five consecutive trading days at any point after closing, the company may issue a news release setting an earlier expiry. Holders would then have 30 days from the date of that release to exercise before the warrants lapse.
Inturai said the money is intended for research and development, business development and general working capital. No breakdown between those three uses was given, and no closing date was stated.
The units are being sold under the listed issuer financing exemption in Part 5A of National Instrument 45-106, a Canadian rule that lets already-listed companies raise limited amounts without a prospectus. Because of that exemption, the shares and warrants sold in the offering will be free-trading immediately in Canada, rather than subject to the usual four-month hold. The offering is available in every Canadian province except Quebec, and in other qualifying jurisdictions including the United States. An offering document has been filed on SEDAR+ and posted on the company's website.
Inturai may also pay finders who introduce subscribers: up to 6 percent of the gross proceeds in cash and finder's warrants equal to up to 6 percent of the units issued to those investors, on the same terms as the investor warrants. Those finder's warrants are subject to a four-month-and-one-day hold. Completion of the financing still requires regulatory approval.
The company describes itself as developing artificial intelligence technologies for applications including healthcare, military, smart homes and industrial settings. The release contains no revenue, contract or product figures against which that description can be assessed. Inturai trades on the CSE under URAI, in the United States as URAIF and in Frankfurt as 3QG0.
Source: PR Newswire
This article is journalism, not investment advice. It is not an offer or solicitation to buy or sell any security. Micro-cap and penny stocks carry a high risk of loss, including illiquidity and dilution. Do your own research.